114 related articles for article (PubMed ID: 8148665)
1. 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with postmenopausal osteoporosis.
Martínez J; Olmos JM; Amado JA; Riancho JA; Freijanes J; González-Macías J
Bone Miner; 1993 Dec; 23(3):207-12. PubMed ID: 8148665
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with primary and secondary hyperparathyroidism.
Martínez J; Olmos JM; de Francisco AL; Amado JA; Riancho JA; González-Macías J
Bone Miner; 1994 Oct; 27(1):25-32. PubMed ID: 7849543
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with renal insufficiency.
Olmos JM; Martínez J; de Francisco AL; Riancho JA; Amado JA; González-Macías J
Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):699-707. PubMed ID: 9922985
[TBL] [Abstract][Full Text] [Related]
4. Sex and age distribution of 1,25(OH)2D3 receptors in peripheral blood mononuclear cells from normal human subjects.
Olmos JM; Amado JA; Riancho JA; Albájar M; González-Macías J
Bone; 1990; 11(6):407-9. PubMed ID: 1964061
[TBL] [Abstract][Full Text] [Related]
5. Calcium absorption in normal and osteoporotic postmenopausal women.
Morris HA; Need AG; Horowitz M; O'Loughlin PD; Nordin BE
Calcif Tissue Int; 1991 Oct; 49(4):240-3. PubMed ID: 1760766
[TBL] [Abstract][Full Text] [Related]
6. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women.
Need AG; Kemp A; Giles N; Morris HA; Horowitz M; Nordin BE
Osteoporos Int; 2002 Jan; 13(1):83-8. PubMed ID: 11883410
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
Hartwell D; Riis BJ; Christiansen C
Calcif Tissue Int; 1990 Dec; 47(6):332-7. PubMed ID: 2292078
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.
D'Amelio P; Grimaldi A; Pescarmona GP; Tamone C; Roato I; Isaia G
FASEB J; 2005 Mar; 19(3):410-2. PubMed ID: 15611151
[TBL] [Abstract][Full Text] [Related]
9. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production by peripheral blood cells in postmenopausal osteoporosis.
Zarrabeitia MT; Riancho JA; Amado JA; Napal J; Gonzalez-Macias J
Bone Miner; 1991 Aug; 14(2):161-7. PubMed ID: 1912764
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
Uenishi K; Tokiwa M; Kato S; Shiraki M
Osteoporos Int; 2018 Mar; 29(3):723-732. PubMed ID: 29273827
[TBL] [Abstract][Full Text] [Related]
12. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
Need AG; Morris HA; Horowitz M; Nordin BE
Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors.
Landin-Wilhelmsen K; Wilhelmsen L; Bengtsson BA
Clin Endocrinol (Oxf); 1999 Oct; 51(4):387-94. PubMed ID: 10583303
[TBL] [Abstract][Full Text] [Related]
14. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years.
Sairanen S; Kärkkäinen M; Tähtelä R; Laitinen K; Mäkelä P; Lamberg-Allardt C; Välimäki MJ
Calcif Tissue Int; 2000 Aug; 67(2):122-7. PubMed ID: 10920216
[TBL] [Abstract][Full Text] [Related]
15. [The effects of oral doses of 1, 25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 on intestinal calcium absorption and serum 1, 25-dihydroxyvitamin D level: a study in healthy adults and in postmenopausal osteoporosis].
Shigeno C; Morita R; Fukunaga M; Yamamoto I; Dokoh S; Hino M; Yamada K; Furumatsu C; Endo K; Mukai T; Iida Y; Torizuka K
Nihon Naibunpi Gakkai Zasshi; 1982 Dec; 58(12):1473-81. PubMed ID: 6897777
[No Abstract] [Full Text] [Related]
16. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
Gallagher JC; Goldgar D
Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
[TBL] [Abstract][Full Text] [Related]
18. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
19. Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study.
van Hoof HJ; van der Mooren MJ; Swinkels LM; Sweep CG; Merkus JM; Benraad TJ
Clin Endocrinol (Oxf); 1999 Apr; 50(4):511-6. PubMed ID: 10468912
[TBL] [Abstract][Full Text] [Related]
20. Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density.
Martínez ME; del Campo MT; Sánchez-Cabezudo MJ; Garcia JA; Sánchez Calvín MT; Torrijos A; Coya J; Munuera L
Calcif Tissue Int; 1994 Oct; 55(4):253-6. PubMed ID: 7820775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
